Hepatic Bmal1 regulates rhythmic mitochondrial dynamics and promotes metabolic fitness. Jacobi D, Liu S, Burkewitz K, Mair WB, Lee CH. Cell Metab 2015; 22:709-720.
A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid utilization. Liu S, Brown JD, Stanya KJ, Homan E, Leidi M, Inouye K, Bhargava P, Gangl MR, Dai L, Hatano B, Hotamisligil GS, Saghatelian A, Plutzky J, Lee CH. Nature 2013; 502:550-553.
Direct control of hepatic glucose production by II-13. Stanya KJ, Jacobi D, Liu S, Bhargava P, Dai L, Gangl MR, Inouye K, Barlow JL, Ji Y, Mizgerd JP, Qi L, Shi H, McKenzie, Lee CH. J Clin Invest 2013, 123:261-271.
Immunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathways. Bhargava P, Li C, Stanya KJ, Jacobi D, Liu S, Dai L, Gangl MR Harn DA, Lee CH. Nat Med 2012. 18:1665-72.
Nuclear receptor corepressor SMRT regulates mitochondrial oxidative metabolism and mediates aging-related metabolic deterioration. Reilly SM, Bhargava P, Liu S, Gangl MR, Gorgun C, Nofsinger RR, Evans RM, Qi L, Hu FB, Lee CH. Cell Metab. 2010 Dec 1;12(6):643-53.
Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Kang K, Reilly SM, Karabacak V, Gangl MR, Fitzgerald K, Hatano B, Lee CH. Cell Metab. 2008 Jun;7(6):485-95.
